Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jul 12, 2014 (12 years ago)

Welchol Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Cause type: Temperature excursion

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled. All temperature excursion recalls.

What was recalled

Welchol Tablets (colesevelam HCl) 625 mg, 180 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 ---NDC 65597-701-18

Affected NDC 65597-0701-18

Compare with the code on your package — it is the most precise check available.

Recalling firm
Daiichi Sankyo Pharma Development
NDC code
65597-701-18
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1505-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Daiichi Sankyo Pharma Development

All 2014 recalls
Class II · Moderate risk

Benicar HCT Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-107-30 D-1508-2014
Class II · Moderate risk

Benicar HCT Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-106-30 D-1507-2014
Class II · Moderate risk

Benicar Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-104-30 D-1506-2014
Class II · Moderate risk

Tribenzor Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-116-30 D-1504-2014

Other temperature excursion recalls from 2014

All temperature excursion recalls